Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Momentum

Open Interest and Volume Dynamics

On 1 April 2026, Divis Laboratories recorded an open interest (OI) of 34,197 contracts, up from 30,862 contracts previously, marking a substantial increase of 3,335 contracts or 10.81%. This rise in OI is accompanied by a futures volume of 19,514 contracts, reflecting active participation in the derivatives market. The futures value stood at ₹26,821.38 lakhs, while the options segment exhibited an enormous notional value of approximately ₹9,272.98 crores, culminating in a total derivatives market value of ₹28,908.31 lakhs for the stock.

The underlying stock price was ₹5,908 at the time, with the stock underperforming its sector by 0.38% on the day. Notably, the stock has been on a four-day losing streak, shedding 2.19% over this period. The intraday high touched ₹6,123, a 2.96% rise from the previous close, but the weighted average price indicates that most volume traded closer to the day’s low, suggesting selling pressure.

Price Trends and Moving Averages

Divis Laboratories is currently trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a bearish technical setup. This persistent weakness is further underscored by rising investor participation, with delivery volumes on 30 March reaching 2.5 lakh shares, a 31.32% increase over the five-day average delivery volume. Such heightened delivery volumes amid falling prices often indicate that investors are offloading shares, possibly in anticipation of further downside or repositioning their portfolios.

Liquidity remains adequate, with the stock’s traded value supporting a trade size of approximately ₹4.27 crores based on 2% of the five-day average traded value, ensuring that market participants can enter or exit positions without significant price impact.

Market Positioning and Directional Bets

The increase in open interest alongside rising volumes in Divis Laboratories’ derivatives suggests that traders are actively repositioning. Given the stock’s recent price weakness and the fact that it trades below all major moving averages, the surge in OI could indicate fresh short positions or protective hedging by existing holders. The elevated options notional value further points to significant activity in option contracts, which may be used to express directional views or volatility plays.

Interestingly, the stock’s Mojo Score has deteriorated to 43.0, with a downgrade from Hold to Sell on 1 February 2026. This downgrade reflects weakening fundamentals or momentum as assessed by MarketsMOJO’s proprietary grading system. The large-cap status of Divis Laboratories, with a market capitalisation of ₹1,62,323 crores, means that institutional investors’ moves in derivatives can have a meaningful impact on price discovery and sentiment.

Comparative Sector and Benchmark Performance

On the day in question, Divis Laboratories’ 1-day return was -1.03%, underperforming the Pharmaceuticals & Biotechnology sector’s -0.59% return. Meanwhile, the broader Sensex gained 1.50%, highlighting the stock’s relative weakness amid a generally positive market environment. This divergence emphasises the stock-specific challenges faced by Divis Laboratories, possibly linked to company-specific news, earnings outlook, or sector rotation.

Investors should note that the rising open interest amid falling prices often signals a strengthening bearish trend, as new short positions add to the downward momentum. However, it can also indicate increased hedging activity by long-term holders seeking to protect gains or limit losses.

Implications for Investors

For investors and traders, the current derivatives activity in Divis Laboratories warrants close monitoring. The 10.8% jump in open interest, combined with the stock’s technical weakness and negative momentum, suggests that bearish sentiment is gaining traction. Those holding long positions may consider protective strategies such as options hedging or reducing exposure, while aggressive traders might explore short-selling opportunities aligned with the prevailing downtrend.

Conversely, contrarian investors should watch for any signs of capitulation or a reversal in open interest trends, which could signal a potential bottoming process. Given the stock’s large-cap stature and liquidity, any significant shift in institutional positioning could rapidly influence price direction.

Overall, the downgrade to a Sell rating by MarketsMOJO, coupled with the deteriorating Mojo Grade from Hold, reinforces a cautious stance on Divis Laboratories in the near term. Investors should weigh these factors carefully against their risk appetite and portfolio objectives.

Summary

Divis Laboratories Ltd’s recent surge in open interest by over 10% in the derivatives market, amid falling prices and underperformance relative to its sector and the Sensex, highlights a growing bearish bias. The stock’s technical indicators remain weak, and increased delivery volumes suggest active investor repositioning. With a Sell rating and a Mojo Score of 43.0, the stock faces headwinds that investors must consider when making allocation decisions. The derivatives market activity provides a valuable lens into market sentiment and potential directional bets, underscoring the importance of monitoring open interest and volume alongside price action.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →